In a testament to its resilient growth strategy, JB Chemicals & Pharmaceuticals announced a 21% rise in profit after tax for the third quarter ending December 2024, achieving Rs 162 crore. This increase was fueled by strong sales in both domestic and international markets.
About the Author
